These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2508448)

  • 21. Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells.
    Koga T; Az-ma T; Yuge O
    Acta Anaesthesiol Scand; 2002 Sep; 46(8):987-93. PubMed ID: 12190800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of endothelin on human platelet aggregation and prostacyclin generation from human vascular endothelial cells in culture.
    Kato K; Sawada S; Toyoda T; Kobayashi K; Shirai K; Yamamoto K; Tamagaki T; Yamagami M; Yoneda M; Takada O
    Jpn Circ J; 1992 May; 56(5):422-31. PubMed ID: 1318427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
    Kalinowski L; Matys T; Chabielska E; Buczko W; Malinski T
    Hypertension; 2002 Oct; 40(4):521-7. PubMed ID: 12364357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets from patients on haemodialysis show impaired responses to nitric oxide.
    Gordge MP; Neild GH
    Clin Sci (Lond); 1992 Sep; 83(3):313-8. PubMed ID: 1327648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet arachidonic acid liberation by endothelium-derived relaxing factor (EDRF) as studied with sin-1, a nitric oxide generating drug. Evidence for calcium-dependent and calcium-independent mechanisms.
    Gassama-Diagne A; Simon MF; Chap H
    J Lipid Mediat; 1992 Feb; 5(1):61-75. PubMed ID: 1327266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation.
    Endresen MJ; Tøsti E; Heimli H; Lorentzen B; Henriksen T
    Scand J Clin Lab Invest; 1994 Nov; 54(7):549-57. PubMed ID: 7863232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discovery of nitric oxide as the endogenous nitrovasodilator.
    Moncada S; Palmer RM; Higgs EA
    Hypertension; 1988 Oct; 12(4):365-72. PubMed ID: 3049340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta(1) restores antiplatelet function of endothelial cells exposed to anoxia-reoxygenation injury.
    Tatsumi M; Kishi Y; Miyata T; Numano F
    Thromb Res; 2000 Jun; 98(5):451-9. PubMed ID: 10828485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cells.
    Houston DS; Robinson P; Gerrard JM
    Blood; 1990 Sep; 76(5):953-8. PubMed ID: 2393718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of collagen- and ADP-induced platelet aggregation by substance P in vivo: involvement of endothelium-derived relaxing factor.
    Humphries RG; Tomlinson W; O'Connor SE; Leff P
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):292-7. PubMed ID: 1697386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation.
    Menter DG; Onoda JM; Moilanen D; Sloane BF; Taylor JD; Honn KV
    J Natl Cancer Inst; 1987 May; 78(5):961-9. PubMed ID: 3553692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and washing of human platelets with nitric oxide.
    Radomski MW; Palmer RM; Read NG; Moncada S
    Thromb Res; 1988 May; 50(4):537-46. PubMed ID: 2842884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.
    Mülsch A; Lückhoff A; Pohl U; Busse R; Bassenge E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):119-25. PubMed ID: 2552329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation.
    Henderson BW; Owczarczak B; Sweeney J; Gessner T
    Photochem Photobiol; 1992 Oct; 56(4):513-21. PubMed ID: 1454881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-dependent potentiation of human platelet aggregation.
    Loeb AL; Peach MJ; Gear AR
    Thromb Res; 1989 Jun; 54(5):477-86. PubMed ID: 2505402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive mediators derived from the endothelium.
    Botting R; Vane JR
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():11-4. PubMed ID: 2514650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
    Stamler J; Mendelsohn ME; Amarante P; Smick D; Andon N; Davies PF; Cooke JP; Loscalzo J
    Circ Res; 1989 Sep; 65(3):789-95. PubMed ID: 2548765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.